Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancer

PURPOSE: Iron deficiency anemia (IDA) is common in cancer patients due to blood loss and inflammation. Many do not tolerate oral iron or adequately respond. Intravenous (IV) iron is commonly used as an adjunct to erythropoiesis-stimulating agents; data on the use of IV iron monotherapy in these pati...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Blood Med
Main Authors: Vadhan-Raj, Saroj, Dahl, Naomi V, Bernard, Kristine, Li, Zhu, Strauss, William E
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2017
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5724711/
https://ncbi.nlm.nih.gov/pubmed/29263710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JBM.S138474
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki